Home > Healthcare > Medical Devices > Diagnostic Devices > Endocrine Testing Market

Endocrine Testing Market Share

  • Report ID: GMI5653
  • Published Date: May 2023
  • Report Format: PDF

Endocrine Testing Market Share

Some of the major players operating in the endocrine testing industry are:

  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG 
  • Abbott Laboratories, Inc.

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for endocrine testing was USD 2.5 billion in 2022 and will exceed USD 5.8 billion by 2032 due to the rising prevalence of chronic conditions, including diabetes, thyroid, and obesity.

Clinical laboratories surpassed USD 1.3 billion in 2022 owing to the higher availability of specialized and efficient diagnosis.

North America endocrine testing market is estimated to reach more than USD 2.1 billion by 2032 due to the influx of supportive reimbursing bodies.

Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, and Abbott Laboratories, Inc. are some of the major endocrine testing companies.

Endocrine Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 16
  • Tables & Figures: 395
  • Countries covered: 30
  • Pages: 200
 Download Free Sample